Evidence map›Paper›PMID 41050607›Full record

ArticleRSC advances2025

Synthesis of nanoparticles of cobalt protoporphyrin IX (Co(iii)PPIX NPs). Antiradical, cytotoxicity and antibacterial properties.

Piotr Fijałkowski, Olga Impert, Paweł Pomastowski, Katarzyna Rafińska, Justyna Walczak-Skierska, Paweł Fijałkowski, Anna Katafias, Rudi van Eldik

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Piotr FijałkowskiCentre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University in Toruń Wileńska 4 87-100 Toruń Poland.ORCID https://orcid.org/0009-0006-8166-7617
Olga ImpertDepartment of Inorganic and Coordination Chemistry, Faculty of Chemistry, Nicolaus Copernicus University in Toruń Gagarina 7 87-100 Toruń Poland oimpert@umk.pl katafias@umk.pl.
Paweł PomastowskiCentre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University in Toruń Wileńska 4 87-100 Toruń Poland.
Katarzyna RafińskaCentre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University in Toruń Wileńska 4 87-100 Toruń Poland.
Justyna Walczak-SkierskaCentre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University in Toruń Wileńska 4 87-100 Toruń Poland.
Paweł FijałkowskiCentre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University in Toruń Wileńska 4 87-100 Toruń Poland.
Anna KatafiasDepartment of Inorganic and Coordination Chemistry, Faculty of Chemistry, Nicolaus Copernicus University in Toruń Gagarina 7 87-100 Toruń Poland oimpert@umk.pl katafias@umk.pl.ORCID https://orcid.org/0000-0001-5536-4280
Rudi van EldikDepartment of Inorganic and Coordination Chemistry, Faculty of Chemistry, Nicolaus Copernicus University in Toruń Gagarina 7 87-100 Toruń Poland oimpert@umk.pl katafias@umk.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porphyrins, composed of a tetrapyrrolic core and various substituents, are highly valued for their photo-, catalytic, electrochemical, and biochemical properties. Protoporphyrin IX (PPIX) is a heterocyclic organic compound whose porphyrin ring enables the chelation of transition metals, resulting in metalloporphyrins with diverse biological functions. Cobalt protoporphyrin IX (Co(iii)PPIX) is known as an inducer of heme oxygenase-1 (HO-1) and has been identified as a potential photosensitiser for use in photodynamic cancer therapy. In this study, Co(iii)PPIX nanoparticles (NPs) were synthesised

Identifiers

PMID41050607
PMCPMC12495410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.